With the recent spate of revelations about illegal clinical trials, a new legislation is set to be put in place that’ll require the consent of patients to be recorded audio-visually. The move will ensure that patients aren’t …
Leading pharma and nutraceutical export player Sami Labs on Monday unveiled a holistic strategy to increase its market share in India to 10 percent in the near future from two percent currently. ‘We are expanding and …
India vouched for the safety and efficacy of drugs manufactured by it and asked African countries not to mix patent issues with those of quality. ‘India is the largest supplier of generic medicines in the world. These drugs are …
The Pharmaceuticals Export Promotion Council of India (Pharmexcil) will host a three-day pharma convention from April 24, an official said on Tuesday. Titled iPHEX 2013, the convention is being organised with the support of the …
India is a ‘hip and happening country’ when it comes to litigations in the pharmaceutical and biotechnology sectors, said a leading patent attorney said on Thursday. ‘I can definitely say that India is a happening country …
As many as 436 people died last year due to serious adverse events (SAE) during clinical trials and the Union Health Minister has said the deaths could be due to life-threatening diseases such as cancer, heart failure and stroke …
In a move to discourage the rampant frequency with which untested drugs are released in India, all pharmaceutical companies that conduct clinical trials will have to register internal ethics committees. The latest gazette …
14 years – that’s how long Deanxit, anti-depressant marketed by a Danish company was sold in this country until its safety and efficacy was questioned. The drug in question is an antidepressant which is mostly marketed in …
The Indian government has approved a new Essential Drug List which increases the number of drugs included in the list and will therefore be subjected to a price-cap. The move will curtail prices of costly brands sold by both …
The centre is working on improved technology to detect spurious drugs, according to joint secretary in the ministry Arun Panda. "The Health Ministry is keen on building its capacities across the country...It is also working on …
Indecipherable prescriptions may soon become a thing of the past. The Maha government has lent its support to the efforts taken by the medical fraternity in the state to create awareness about handwriting legibility amongst docs …
India is working to strengthen policies related to drug regulation in order to check spurious drugs in the market, Minister of State for Health Sudip Bandyopadhyay said. Speaking at a two-day international workshop here on …
In a bid to crack down on illegal commercial sale of drugs the CDSCO has written to all state and zonal drug inspectors to conduct surprise inspections across the six lakh chemist shops scattered around the country. These drugs …
The Drug Controller General of India (DCGI) has asked all pharmaceutical companies to submit safety details of their new drugs every six months after their launch, failing which their licenses would be cancelled. They’re …
